| Product NDC: | 55154-6980 |
| Proprietary Name: | Naloxone Hydrochloride |
| Non Proprietary Name: | NALOXONE HYDROCHLORIDE |
| Active Ingredient(s): | .4 mg/mL & nbsp; NALOXONE HYDROCHLORIDE |
| Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 55154-6980 |
| Labeler Name: | Cardinal Health |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA070256 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20110708 |
| Package NDC: | 55154-6980-8 |
| Package Description: | 1 VIAL, SINGLE-DOSE in 1 BAG (55154-6980-8) > 1 mL in 1 VIAL, SINGLE-DOSE |
| NDC Code | 55154-6980-8 |
| Proprietary Name | Naloxone Hydrochloride |
| Package Description | 1 VIAL, SINGLE-DOSE in 1 BAG (55154-6980-8) > 1 mL in 1 VIAL, SINGLE-DOSE |
| Product NDC | 55154-6980 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | NALOXONE HYDROCHLORIDE |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAMUSCULAR; INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20110708 |
| Marketing Category Name | ANDA |
| Labeler Name | Cardinal Health |
| Substance Name | NALOXONE HYDROCHLORIDE |
| Strength Number | .4 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Opioid Antagonist [EPC],Opioid Antagonists [MoA] |